14-day Premium Trial Subscription Try For FreeTry Free
$15.02
-0.180 (-1.18%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $14.59 $16.25 Thursday, 2nd May 2024 CPRX stock ended at $15.02. This is 1.18% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.25% from a day low at $14.84 to a day high of $15.47.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
Dec 14, 2020 $3.72 $3.99 $3.57 $3.83 3 435 321
Dec 11, 2020 $3.65 $3.69 $3.54 $3.63 2 220 085
Dec 10, 2020 $3.51 $3.63 $3.46 $3.61 1 645 666
Dec 09, 2020 $3.60 $3.67 $3.42 $3.54 2 507 108
Dec 08, 2020 $3.46 $3.55 $3.38 $3.55 1 542 521
Dec 07, 2020 $3.62 $3.63 $3.41 $3.43 1 826 929
Dec 04, 2020 $3.65 $3.66 $3.56 $3.59 1 141 990
Dec 03, 2020 $3.58 $3.65 $3.55 $3.63 1 539 522
Dec 02, 2020 $3.56 $3.58 $3.45 $3.54 1 400 380
Dec 01, 2020 $3.73 $3.74 $3.51 $3.54 1 545 959
Nov 30, 2020 $3.83 $3.84 $3.58 $3.66 2 091 963
Nov 27, 2020 $3.53 $3.72 $3.51 $3.70 1 132 961
Nov 25, 2020 $3.50 $3.59 $3.47 $3.49 1 352 271
Nov 24, 2020 $3.49 $3.54 $3.39 $3.48 1 975 391
Nov 23, 2020 $3.37 $3.46 $3.35 $3.44 1 337 942
Nov 20, 2020 $3.30 $3.35 $3.25 $3.35 1 167 674
Nov 19, 2020 $3.27 $3.33 $3.22 $3.32 1 891 321
Nov 18, 2020 $3.37 $3.38 $3.26 $3.26 1 305 983
Nov 17, 2020 $3.40 $3.40 $3.25 $3.32 1 369 623
Nov 16, 2020 $3.44 $3.51 $3.30 $3.36 1 722 353
Nov 13, 2020 $3.41 $3.44 $3.35 $3.40 1 238 734
Nov 12, 2020 $3.44 $3.55 $3.34 $3.35 1 440 393
Nov 11, 2020 $3.41 $3.46 $3.37 $3.40 979 834
Nov 10, 2020 $3.41 $3.45 $3.32 $3.40 1 920 923
Nov 09, 2020 $3.30 $3.36 $3.21 $3.31 1 725 474
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT